Cargando…

Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study

BACKGROUND: Research examining the role of obesity in cardiovascular disease (CVD) often fails to adequately consider heterogeneity in obesity severity, distribution, and duration. METHODS AND RESULTS: We here use multivariate latent class mixed models in the biracial Atherosclerosis Risk in Communi...

Descripción completa

Detalles Bibliográficos
Autores principales: Raffield, Laura M., Howard, Annie Green, Graff, Misa, Lin, Dan‐Yu, Cheng, Susan, Demerath, Ellen, Ndumele, Chiadi, Palta, Priya, Rebholz, Casey M., Seidelmann, Sara, Yu, Bing, Gordon‐Larsen, Penny, North, Kari E., Avery, Christy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075238/
https://www.ncbi.nlm.nih.gov/pubmed/34889111
http://dx.doi.org/10.1161/JAHA.121.019946
_version_ 1784701637049188352
author Raffield, Laura M.
Howard, Annie Green
Graff, Misa
Lin, Dan‐Yu
Cheng, Susan
Demerath, Ellen
Ndumele, Chiadi
Palta, Priya
Rebholz, Casey M.
Seidelmann, Sara
Yu, Bing
Gordon‐Larsen, Penny
North, Kari E.
Avery, Christy L.
author_facet Raffield, Laura M.
Howard, Annie Green
Graff, Misa
Lin, Dan‐Yu
Cheng, Susan
Demerath, Ellen
Ndumele, Chiadi
Palta, Priya
Rebholz, Casey M.
Seidelmann, Sara
Yu, Bing
Gordon‐Larsen, Penny
North, Kari E.
Avery, Christy L.
author_sort Raffield, Laura M.
collection PubMed
description BACKGROUND: Research examining the role of obesity in cardiovascular disease (CVD) often fails to adequately consider heterogeneity in obesity severity, distribution, and duration. METHODS AND RESULTS: We here use multivariate latent class mixed models in the biracial Atherosclerosis Risk in Communities study (N=14 514; mean age=54 years; 55% female) to associate obesity subclasses (derived from body mass index, waist circumference, self‐reported weight at age 25, tricep skinfold, and calf circumference across up to four triennial visits) with total mortality, incident CVD, and CVD risk factors. We identified four obesity subclasses, summarized by their body mass index and waist circumference slope as decline (4.1%), stable/slow decline (67.8%), moderate increase (24.6%), and rapid increase (3.6%) subclasses. Compared with participants in the stable/slow decline subclass, the decline subclass was associated with elevated mortality (hazard ratio [HR] 1.45, 95% CI 1.31, 1.60, P<0.0001) and with heart failure (HR 1.41, 95% CI 1.22, 1.63, P<0.0001), stroke (HR 1.53, 95% CI 1.22, 1.92, P=0.0002), and coronary heart disease (HR 1.36, 95% CI 1.14, 1.63, P=0.0008), adjusting for baseline body mass index and CVD risk factor profile. The moderate increase latent class was not associated with any significant differences in CVD risk as compared to the stable/slow decline latent class and was associated with a lower overall risk of mortality (HR 0.85, 95% CI 0.80, 0.90, P<0.0001), despite higher body mass index at baseline. The rapid increase latent class was associated with a higher risk of heart failure versus the stable/slow decline latent class (HR 1.34, 95% CI 1.10, 1.62, P=0.004). CONCLUSIONS: Consideration of heterogeneity and longitudinal changes in obesity measures is needed in clinical care for a more precision‐oriented view of CVD risk.
format Online
Article
Text
id pubmed-9075238
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90752382022-05-10 Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study Raffield, Laura M. Howard, Annie Green Graff, Misa Lin, Dan‐Yu Cheng, Susan Demerath, Ellen Ndumele, Chiadi Palta, Priya Rebholz, Casey M. Seidelmann, Sara Yu, Bing Gordon‐Larsen, Penny North, Kari E. Avery, Christy L. J Am Heart Assoc Original Research BACKGROUND: Research examining the role of obesity in cardiovascular disease (CVD) often fails to adequately consider heterogeneity in obesity severity, distribution, and duration. METHODS AND RESULTS: We here use multivariate latent class mixed models in the biracial Atherosclerosis Risk in Communities study (N=14 514; mean age=54 years; 55% female) to associate obesity subclasses (derived from body mass index, waist circumference, self‐reported weight at age 25, tricep skinfold, and calf circumference across up to four triennial visits) with total mortality, incident CVD, and CVD risk factors. We identified four obesity subclasses, summarized by their body mass index and waist circumference slope as decline (4.1%), stable/slow decline (67.8%), moderate increase (24.6%), and rapid increase (3.6%) subclasses. Compared with participants in the stable/slow decline subclass, the decline subclass was associated with elevated mortality (hazard ratio [HR] 1.45, 95% CI 1.31, 1.60, P<0.0001) and with heart failure (HR 1.41, 95% CI 1.22, 1.63, P<0.0001), stroke (HR 1.53, 95% CI 1.22, 1.92, P=0.0002), and coronary heart disease (HR 1.36, 95% CI 1.14, 1.63, P=0.0008), adjusting for baseline body mass index and CVD risk factor profile. The moderate increase latent class was not associated with any significant differences in CVD risk as compared to the stable/slow decline latent class and was associated with a lower overall risk of mortality (HR 0.85, 95% CI 0.80, 0.90, P<0.0001), despite higher body mass index at baseline. The rapid increase latent class was associated with a higher risk of heart failure versus the stable/slow decline latent class (HR 1.34, 95% CI 1.10, 1.62, P=0.004). CONCLUSIONS: Consideration of heterogeneity and longitudinal changes in obesity measures is needed in clinical care for a more precision‐oriented view of CVD risk. John Wiley and Sons Inc. 2021-12-10 /pmc/articles/PMC9075238/ /pubmed/34889111 http://dx.doi.org/10.1161/JAHA.121.019946 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Raffield, Laura M.
Howard, Annie Green
Graff, Misa
Lin, Dan‐Yu
Cheng, Susan
Demerath, Ellen
Ndumele, Chiadi
Palta, Priya
Rebholz, Casey M.
Seidelmann, Sara
Yu, Bing
Gordon‐Larsen, Penny
North, Kari E.
Avery, Christy L.
Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study
title Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study
title_full Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study
title_fullStr Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study
title_full_unstemmed Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study
title_short Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study
title_sort obesity duration, severity, and distribution trajectories and cardiovascular disease risk in the atherosclerosis risk in communities study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075238/
https://www.ncbi.nlm.nih.gov/pubmed/34889111
http://dx.doi.org/10.1161/JAHA.121.019946
work_keys_str_mv AT raffieldlauram obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT howardanniegreen obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT graffmisa obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT lindanyu obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT chengsusan obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT demerathellen obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT ndumelechiadi obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT paltapriya obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT rebholzcaseym obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT seidelmannsara obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT yubing obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT gordonlarsenpenny obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT northkarie obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy
AT averychristyl obesitydurationseverityanddistributiontrajectoriesandcardiovasculardiseaseriskintheatherosclerosisriskincommunitiesstudy